THEROSCA

Serial Number 98519464
731

Registration Progress

Application Filed
Apr 25, 2024
Under Examination
Jan 7, 2025
Approved for Publication
Nov 26, 2024
Published for Opposition
Nov 26, 2024
Registered

Attorney Assistance

NOA E-Mailed - SOU Required
Due: Jul 07, 2026 197 days

Trademark Image

THEROSCA

Basic Information

Serial Number
98519464
Filing Date
April 25, 2024
Published for Opposition
November 26, 2024
Drawing Code
4

Status Summary

Current Status
Active
Status Code
731
Status Date
Dec 1, 2025
Application
Pending
Classes
005

Rights Holder

Pfizer Inc.

03
Address
66 Hudson Boulevard East
New York, NY 10001-2192

Ownership History

Pfizer Inc.

Original Applicant
03
New York, NY

Pfizer Inc.

Owner at Publication
03
New York, NY

Legal Representation

Attorney
Janina Gorbach

USPTO Deadlines

Next Deadline
197 days remaining
NOA E-Mailed - SOU Required
Due Date
July 07, 2026
Extension Available
Until January 07, 2027

Application History

16 events
Date Code Type Description Documents
Dec 2, 2025 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Dec 1, 2025 EX2G S SOU EXTENSION 2 GRANTED Loading...
Dec 1, 2025 EXT2 S SOU EXTENSION 2 FILED Loading...
Dec 1, 2025 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Sep 15, 2025 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
May 30, 2025 EX1G S SOU EXTENSION 1 GRANTED Loading...
May 30, 2025 EXT1 S SOU EXTENSION 1 FILED Loading...
May 30, 2025 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Jan 7, 2025 NOAM E NOA E-MAILED - SOU REQUIRED FROM APPLICANT Loading...
Nov 26, 2024 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Loading...
Nov 26, 2024 PUBO A PUBLISHED FOR OPPOSITION Loading...
Nov 20, 2024 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Loading...
Nov 1, 2024 CNSA P APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
Oct 30, 2024 DOCK D ASSIGNED TO EXAMINER Loading...
Oct 17, 2024 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Loading...
Apr 25, 2024 NWAP I NEW APPLICATION ENTERED Loading...

Detailed Classifications

Class 005
Pharmaceutical preparations for the treatment of autoimmune, cardiovascular, central nervous system, endocrine, gastrointestinal, genetic, infectious, inflammatory, kidney, liver, menopausal, metabolic, musculoskeletal, neurodegenerative, neurological, neuromuscular and viral diseases and disorders; pharmaceutical preparations for the treatment of blood disorders, bone growth disorders, skin disorders, arthritis, cancer, hypertension, pain, stroke, obesity and diabetes; pharmaceutical preparations, namely, anti-infective preparations, medicated dermatological preparations and smoking cessation preparations; vaccines for human use

Classification

International Classes
005